You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

COSYNTROPIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cosyntropin, and what generic alternatives are available?

Cosyntropin is a drug marketed by Mylan Institutional and Sandoz and is included in three NDAs.

The generic ingredient in COSYNTROPIN is cosyntropin. There are two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cosyntropin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cosyntropin

A generic version of COSYNTROPIN was approved as cosyntropin by SANDOZ on June 29th, 2012.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for COSYNTROPIN?
  • What are the global sales for COSYNTROPIN?
  • What is Average Wholesale Price for COSYNTROPIN?
Drug patent expirations by year for COSYNTROPIN
Recent Clinical Trials for COSYNTROPIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chongqing Medical UniversityN/A
Hill Dermaceuticals, Inc.Phase 1/Phase 2
Synteract, Inc.Phase 1/Phase 2

See all COSYNTROPIN clinical trials

Pharmacology for COSYNTROPIN
Medical Subject Heading (MeSH) Categories for COSYNTROPIN

US Patents and Regulatory Information for COSYNTROPIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional COSYNTROPIN cosyntropin INJECTABLE;INJECTION 090574-001 Dec 17, 2009 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz COSYNTROPIN cosyntropin INJECTABLE;INJECTION 202147-001 Jun 29, 2012 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz COSYNTROPIN cosyntropin SOLUTION;INTRAVENOUS 022028-001 Feb 21, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.